Literature DB >> 20699220

Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1.

Atsushi Iwai1, Takuya Shiozaki, Taro Kawai, Shizuo Akira, Yoshihiro Kawaoka, Ayato Takada, Hiroshi Kida, Tadaaki Miyazaki.   

Abstract

Type I interferons (IFNs) are known to be critical factors in the activation of host antiviral responses and are also important in protection from influenza A virus infection. Especially, the RIG-I- and IPS-1-mediated intracellular type I IFN-inducing pathway is essential in the activation of antiviral responses in cells infected by influenza A virus. Previously, it has been reported that influenza A virus NS1 is involved in the inhibition of this pathway. We show in this report that the influenza A virus utilizes another critical inhibitory mechanism in this pathway. In fact, the viral polymerase complex exhibited an inhibitory activity on IFNβ promoter activation mediated by RIG-I and IPS-1, and this activity was not competitive with the function of NS1. Co-immunoprecipitation analysis revealed that each polymerase subunit bound to IPS-1 in mammalian cells, and each subunit inhibited the activation of IFNβ promoter by IPS-1 independently. In addition, by a combinational expression of each polymerase subunit, IPS-1-induced activation of IFNβ promoter was more efficiently inhibited by the expression of PB2 or PB2-containing complex. Moreover, the expression of PB2 inhibited the transcription of the endogenous IFNβ gene induced after influenza A virus infection. These findings demonstrate that the viral polymerase plays an important role for regulating host anti-viral response through the binding to IPS-1 and inhibition of IFNβ production.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20699220      PMCID: PMC2952208          DOI: 10.1074/jbc.M110.112458

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

1.  VISA is an adapter protein required for virus-triggered IFN-beta signaling.

Authors:  Liang-Guo Xu; Yan-Yi Wang; Ke-Jun Han; Lian-Yun Li; Zhonghe Zhai; Hong-Bing Shu
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

Review 2.  Pathogen recognition: TLRs throw us a curve.

Authors:  Peter Kirk; J Fernando Bazan
Journal:  Immunity       Date:  2005-10       Impact factor: 31.745

Review 3.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

Review 4.  Intracellular pattern recognition receptors in the host response.

Authors:  Etienne Meylan; Jürg Tschopp; Michael Karin
Journal:  Nature       Date:  2006-07-06       Impact factor: 49.962

5.  Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.

Authors:  Eileen Foy; Kui Li; Rhea Sumpter; Yueh-Ming Loo; Cynthia L Johnson; Chunfu Wang; Penny Mar Fish; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

6.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.

Authors:  Etienne Meylan; Joseph Curran; Kay Hofmann; Darius Moradpour; Marco Binder; Ralf Bartenschlager; Jürg Tschopp
Journal:  Nature       Date:  2005-09-21       Impact factor: 49.962

7.  Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.

Authors:  Washington B Cárdenas; Yueh-Ming Loo; Michael Gale; Amy L Hartman; Christopher R Kimberlin; Luis Martínez-Sobrido; Erica Ollmann Saphire; Christopher F Basler
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

8.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction.

Authors:  Taro Kawai; Ken Takahashi; Shintaro Sato; Cevayir Coban; Himanshu Kumar; Hiroki Kato; Ken J Ishii; Osamu Takeuchi; Shizuo Akira
Journal:  Nat Immunol       Date:  2005-08-28       Impact factor: 25.606

9.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.

Authors:  Rashu B Seth; Lijun Sun; Chee-Kwee Ea; Zhijian J Chen
Journal:  Cell       Date:  2005-09-09       Impact factor: 41.582

10.  Characterization of a mitochondrial-targeting signal in the PB2 protein of influenza viruses.

Authors:  Simon M Carr; Elena Carnero; Adolfo García-Sastre; George G Brownlee; Ervin Fodor
Journal:  Virology       Date:  2005-10-18       Impact factor: 3.616

View more
  68 in total

1.  Double Plant Homeodomain Fingers 2 (DPF2) Promotes the Immune Escape of Influenza Virus by Suppressing Beta Interferon Production.

Authors:  Dongjo Shin; Jihye Lee; Ji Hoon Park; Ji-Young Min
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

Review 2.  To Conquer the Host, Influenza Virus Is Packing It In: Interferon-Antagonistic Strategies beyond NS1.

Authors:  Michaela Weber-Gerlach; Friedemann Weber
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

3.  Influenza A virus protein PB1-F2 impairs innate immunity by inducing mitophagy.

Authors:  Ruifang Wang; Yinxing Zhu; Chenwei Ren; Shuaike Yang; Shan Tian; Huanchun Chen; Meilin Jin; Hongbo Zhou
Journal:  Autophagy       Date:  2020-02-11       Impact factor: 16.016

4.  PB2-588I enhances 2009 H1N1 pandemic influenza virus virulence by increasing viral replication and exacerbating PB2 inhibition of beta interferon expression.

Authors:  Zongzheng Zhao; Chenyang Yi; Lianzhong Zhao; Shengyu Wang; Lishan Zhou; Yong Hu; Wei Zou; Huanchun Chen; Meilin Jin
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

5.  Specific Mutations in the PB2 Protein of Influenza A Virus Compensate for the Lack of Efficient Interferon Antagonism of the NS1 Protein of Bat Influenza A-Like Viruses.

Authors:  Teresa Aydillo; Juan Ayllon; Amzie Pavlisin; Carles Martinez-Romero; Shashank Tripathi; Ignacio Mena; Andrés Moreira-Soto; Amanda Vicente-Santos; Eugenia Corrales-Aguilar; Martin Schwemmle; Adolfo García-Sastre
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

6.  Comprehensive proteomic analysis of influenza virus polymerase complex reveals a novel association with mitochondrial proteins and RNA polymerase accessory factors.

Authors:  Birgit G Bradel-Tretheway; Jonelle L Mattiacio; Alexei Krasnoselsky; Catherine Stevenson; David Purdy; Stephen Dewhurst; Michael G Katze
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

Review 7.  Genetic Dissection of the Host Tropism of Human-Tropic Pathogens.

Authors:  Florian Douam; Jenna M Gaska; Benjamin Y Winer; Qiang Ding; Markus von Schaewen; Alexander Ploss
Journal:  Annu Rev Genet       Date:  2015-09-25       Impact factor: 16.830

8.  Identification of a Novel Viral Protein Expressed from the PB2 Segment of Influenza A Virus.

Authors:  Seiya Yamayoshi; Mariko Watanabe; Hideo Goto; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

9.  Differences in cytokine production in human macrophages and in virulence in mice are attributable to the acidic polymerase protein of highly pathogenic influenza A virus subtype H5N1.

Authors:  Saori Sakabe; Ryo Takano; Tokiko Nagamura-Inoue; Naohide Yamashita; Chairul A Nidom; Mai thi Quynh Le; Kiyoko Iwatsuki-Horimoto; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2012-10-04       Impact factor: 5.226

10.  Synergistic effect of the PDZ and p85β-binding domains of the NS1 protein on virulence of an avian H5N1 influenza A virus.

Authors:  Shufang Fan; Catherine A Macken; Chengjun Li; Makoto Ozawa; Hideo Goto; N F N Iswahyudi; Chairul A Nidom; Hualan Chen; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.